“Current status of anti-CD30 monoclonal antibody therapy in anaplastic lymphoma and Hodgkin’s lymphoma”, Hematol Meeting Rep, vol. 2, no. 13, Jun. 2009, doi: 10.4081/hmr.v2i13.483.